An eight-gene riskscore model and computational evaluation of the PDGFRB-imatinib interaction in HBV-positive hepatocellular carcinoma
Letters in Drug Design & Discovery · 2026-09 · 23 (9) · 100595
DOI: 10.1016/j.lddd.2026.100595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-09. Verfasst von Chao Chen und 2 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chen, C., Jiang, H., & Pan, Y. (2026). An eight-gene riskscore model and computational evaluation of the PDGFRB-imatinib interaction in HBV-positive hepatocellular carcinoma. Letters in Drug Design & Discovery, 23(9), 100595. https://doi.org/10.1016/j.lddd.2026.100595
Vancouver
Chen C, Jiang H, Pan Y. An eight-gene riskscore model and computational evaluation of the PDGFRB-imatinib interaction in HBV-positive hepatocellular carcinoma. Letters in Drug Design & Discovery. 2026;23(9):100595. doi:10.1016/j.lddd.2026.100595
BibTeX
@article{Chen2026,
author = {Chen, Chao and Jiang, Hao and Pan, Yuan},
title = {An eight-gene riskscore model and computational evaluation of the PDGFRB-imatinib interaction in HBV-positive hepatocellular carcinoma},
journal = {Letters in Drug Design & Discovery},
year = {2026},
volume = {23},
number = {9},
pages = {100595},
doi = {10.1016/j.lddd.2026.100595}
}
EUVIMED